Sökning: onr:"swepub:oai:gup.ub.gu.se/312197" >
Neurodevelopmental ...
-
Liu, S. X.Karolinska Institutet
(författare)
Neurodevelopmental Disorders, Glycemic Control, and Diabetic Complications in Type 1 Diabetes: a Nationwide Cohort Study
- Artikel/kapitelEngelska2021
Förlag, utgivningsår, omfång ...
-
2021-06-25
-
Cary, NC :The Endocrine Society,2021
Nummerbeteckningar
-
LIBRIS-ID:oai:gup.ub.gu.se/312197
-
https://gup.ub.gu.se/publication/312197URI
-
https://doi.org/10.1210/clinem/dgab467DOI
-
https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-92681URI
-
https://urn.kb.se/resolve?urn=urn:nbn:se:hh:diva-45915URI
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:148146576URI
Kompletterande språkuppgifter
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
Funding agency:Karolinska Institutet, Strategic Research Program in Neuroscience (StratNeuro)
-
Funding: The Swedish Research Council (No 2017-00788), Stockholm Region Council (No 20180718) and Karolinska Institutet, Strategic Research Program in Neuroscience (StratNeuro).
-
Context: Neurodevelopmental disorders are more prevalent in childhood-onset type 1 diabetes than in the general population, and the symptoms may limit the individual's ability for diabetes management. Objective: This study investigated whether comorbid neurodevelopmental disorders are associated with long-term glycemic control and risk of diabetic complications. Methods: This population-based cohort study used longitudinally collected data from Swedish registers. We identified 11 326 individuals born during 1973-2013, diagnosed with type 1 diabetes during 1990-2013 (median onset age: 9.6 years). Among them, 764 had a comorbid neurodevelopmental disorder, including attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder, and intellectual disability. We used multinomial logistic regression to calculate odds ratios (ORs) of having poor glycemic control (assessed by glycated hemoglobin [HbA(1c)]) and Cox regression to estimate hazard ratios (HRs) of nephropathy and retinopathy. Results: The median follow-up was 7.5 years (interquartile range [IQR] 3.9, 11.2). Having any neurodevelopmental disorder (ORadjusted 1.51 [95% CI 1.13, 2.03]), or ADHD (ORadjusted 2.31 [95% CI 1.54, 3.45]) was associated with poor glycemic control (mean HbA(1c) > 8.5%). Increased risk of diabetic complications was observed in patients with comorbid neurodevelopmental disorders (HRadjusted 1.72 [95% CI 1.21, 2.44] for nephropathy, HRadjusted 1.18 [95% CI 1.00, 1.40] for retinopathy) and patients with ADHD (HRadjusted 1.90 [95% CI 1.20, 3.00] for nephropathy, HRadjusted 1.33 [95% CI 1.07, 1.66] for retinopathy). Patients with intellectual disability have a particularly higher risk of nephropathy (HRadjusted 2.64 [95% CI 1.30, 5.37]). Conclusion: Comorbid neurodevelopmental disorders, primarily ADHD and intellectual disability, were associated with poor glycemic control and a higher risk of diabetic complications in childhood-onset type 1 diabetes.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Kuja-Halkola, R.Karolinska Institutet
(författare)
-
Larsson, Henrik,1975-Karolinska Institutet,Örebro universitet,Institutionen för medicinska vetenskaper,Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna, Sweden; School of Medical Sciences, Örebro University, Örebro, Sweden(Swepub:oru)hiln
(författare)
-
Lichtenstein, P.Karolinska Institutet
(författare)
-
Ludvigsson, Jonas F.,1969-Karolinska Institutet(Swepub:oru)jsln
(författare)
-
Svensson, Ann-Marie,1961Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine,Swedish National Diabetes Register, Centre of Registers, Gothenburg, Sweden; School of Health and Social Science, Halmstad University, Halmstad, Sweden,Swedish National Diabetes Register, Centre of Registers, Gothenburg, Sweden; Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden(Swepub:gu)xsannh
(författare)
-
Gudbjörnsdottir, Soffia,1962Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine,Swedish National Diabetes Register, Centre of Registers, Gothenburg, Sweden; Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden(Swepub:gu)xgudso
(författare)
-
Tideman, Magnus,1959-Högskolan i Halmstad,Wigforss-gruppen(Swepub:hh)mati
(författare)
-
Serlachius, E.Karolinska Institutet
(författare)
-
Butwicka, A.Karolinska Institutet
(författare)
-
Karolinska InstitutetInstitutionen för medicinska vetenskaper
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Journal of Clinical Endocrinology & MetabolismCary, NC : The Endocrine Society106:110021-972X1945-7197
Internetlänk
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Liu, S. X.
-
Kuja-Halkola, R.
-
Larsson, Henrik, ...
-
Lichtenstein, P.
-
Ludvigsson, Jona ...
-
Svensson, Ann-Ma ...
-
visa fler...
-
Gudbjörnsdottir, ...
-
Tideman, Magnus, ...
-
Serlachius, E.
-
Butwicka, A.
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Medicinska och f ...
-
och Neurovetenskaper
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Endokrinologi oc ...
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Psykiatri
- Artiklar i publikationen
-
Journal of Clini ...
- Av lärosätet
-
Göteborgs universitet
-
Örebro universitet
-
Högskolan i Halmstad
-
Karolinska Institutet